Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term atorvastatin treatment in primary biliary cirrhosis
2005-002160-28Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of atorvastatin in primary biliary cholangitis (PBC) and hypercholesterolemia (2 cohorts), sponsored by Medical University of Graz. Primary endpoint: LDL-cholesterol. Started Aug 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
primary biliary cholangitis (PBC)hypercholesterolemia
Beyond the preview
Go deeper on 2005-002160-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002160-28.